Moyamoya disease and moyamoya syndrome

RM Scott, ER Smith - New England Journal of Medicine, 2009 - Mass Medical Soc
Moyamoya disease is a cerebrovascular condition predisposing affected patients to stroke in
association with progressive stenosis of the intracranial internal carotid arteries and their …

Moyamoya disease: current concepts and future perspectives

S Kuroda, K Houkin - The Lancet Neurology, 2008 - thelancet.com
Moyamoya disease is an uncommon cerebrovascular disease that is characterised by
progressive stenosis of the terminal portion of the internal carotid artery and its main …

2021 Japanese guidelines for the management of Moyamoya disease: guidelines from the research committee on Moyamoya disease and Japan stroke society

M Fujimura, T Tominaga, S Kuroda… - Neurologia medico …, 2022 - jstage.jst.go.jp
1Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo,
Hokkaido, Japan 2Department of Neurosurgery, Tohoku University Graduate School of …

Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical …

P Monagle, AKC Chan, NA Goldenberg, RN Ichord… - Chest, 2012 - Elsevier
Background Neonates and children differ from adults in physiology, pharmacologic
responses to drugs, epidemiology, and long-term consequences of thrombosis. This …

Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)

RC on the Pathology - Neurologia medico-chirurgica, 2012 - pubmed.ncbi.nlm.nih.gov
Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the
circle of Willis) Guidelines for diagnosis and treatment of moyamoya disease (spontaneous …

Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on …

ES Roach, MR Golomb, R Adams, J Biller, S Daniels… - Stroke, 2008 - Am Heart Assoc
Purpose—The purpose of this statement is to review the literature on childhood stroke and to
provide recommendations for optimal diagnosis and treatment. This statement is intended …

Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials

J Liu, Y Wang, Y Akamatsu, CC Lee, RA Stetler… - Progress in …, 2014 - Elsevier
The brain vasculature has been increasingly recognized as a key player that directs brain
development, regulates homeostasis, and contributes to pathological processes. Following …

[HTML][HTML] Moyamoya disease: treatment and outcomes

T Kim, CW Oh, JS Bang, JE Kim, WS Cho - Journal of stroke, 2016 - ncbi.nlm.nih.gov
Although the pathogenesis of moyamoya disease (MMD) has not been fully elucidated, the
effectiveness of surgical revascularization in preventing stroke has been addressed by many …

Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease

DC Guo, CL Papke, V Tran-Fadulu… - The American Journal of …, 2009 - cell.com
The vascular smooth muscle cell (SMC)-specific isoform of α-actin (ACTA2) is a major
component of the contractile apparatus in SMCs located throughout the arterial system …

Clinical outcome after 450 revascularization procedures for moyamoya disease

R Guzman, M Lee, A Achrol, T Bell-Stephens… - Journal of …, 2009 - thejns.org
Object Moyamoya disease (MMD) is a rare cerebrovascular disease mainly described in the
Asian literature. To address a lack of data on clinical characteristics and long-term outcomes …